Filing Details
- Accession Number:
- 0001562180-21-005939
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-14 10:45:01
- Reporting Period:
- 2021-09-10
- Accepted Time:
- 2021-09-14 10:45:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 105770 | West Pharmaceutical Services Inc | WST | Fabricated Rubber Products, Nec (3060) | 231210010 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1744326 | J Quintin Lai | 530 Herman O. West Drive Exton PA 19341 | Vp Corp Development & Strategy | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-10 | 8,672 | $59.64 | 10,906 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-09-10 | 1,000 | $72.97 | 11,906 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-09-10 | 5,072 | $460.18 | 6,834 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-10 | 3,100 | $460.80 | 3,734 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-09-10 | 1,500 | $462.63 | 2,234 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-09-10 | 8,672 | $0.00 | 8,672 | $59.64 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-09-10 | 1,000 | $0.00 | 1,000 | $72.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-02-23 | 2026-02-23 | No | 4 | M | Direct |
| 0 | 2017-10-18 | 2026-10-18 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $459.50 to $460.44, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $460.50 to $461.44, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $462.48 to $462.805, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
Billionaire Hedge Funds
